Latest Biotech News

The biotech sector is experiencing variable dynamics amidst funding shifts and market uncertainty. Recursion Pharmaceuticals is restructuring with a 20% workforce reduction amid pipeline...

AI is reshaping drug discovery and healthcare innovation. Exciting developments include the launch of Insilico Medicine’s Nach01 foundation model on AWS Marketplace to accelerate generative...

Collaborative efforts are propelling Alzheimer's research forward through large-scale integrative proteomics and biomarker discovery. Alamar Biosciences, along with partners including Gates...

Innovative cancer research has yielded promising therapeutic and diagnostic advances. A new nanoparticle vaccine shows efficacy in eradicating pancreatic cancer tumors in preclinical models,...

Recent breakthroughs in gene therapy and genome editing technologies highlight a surge in precision medicine approaches. SpliceBio secured a $135 million Series B to advance its FDA-authorized...

The FDA imposed a clinical hold on five studies testing Gilead’s investigational long-acting HIV pill combination GS-1720 and GS-4182 following immune cell count declines in some participants....

Livanova plc is petitioning CMS to remove the coverage with evidence development mandate for its vagus nerve stimulation device for treatment-resistant depression, aiming to streamline patient...

Merck’s monoclonal antibody Enflonsia (clesrovimab) received FDA approval to prevent RSV lower respiratory tract disease in infants under 12 months, entering a competitive pediatric market...

Over 300 current and former NIH employees have signed the Bethesda Declaration, a formal letter addressed to NIH Director Jay Bhattacharya, criticizing recent grant cancellations, funding freezes,...

Alamar Biosciences, in partnership with the Alzheimer’s Disease Data Initiative and Gates Ventures, initiated a large-scale proteomic profiling project using ultra-sensitive NULISA™ technology...

Recently published research highlights the transformative potential of DNA methylation and hydroxymethylation sequencing technologies in enabling early cancer detection. By profiling methylation...

A comprehensive study from UC San Diego catalogs 851 distinct N-acyl lipids across human tissues and biofluids, including 777 previously unidentified compounds. The findings illuminate crucial...

Researchers led by Nagoya University unveiled a next-generation CAR-T cell therapy designed to target solid tumors by recognizing the antigen Eva1 (MPZL2), expressed prevalently in lung,...

Northwestern University researchers have developed an advanced generative AI computational model, leveraging a transcriptome-wide conditional variational autoencoder (TWAVE), to identify key gene...

AI-driven drug developer Recursion Pharmaceuticals announced layoffs constituting approximately 20% of its workforce, equating to 160 positions, reflecting its pipeline streamlining and...

Antares Therapeutics, formed as a spinout from Scorpion Therapeutics after Lilly’s acquisition, has raised $177 million in a Series A round to continue advancing preclinical oncology drug...

The FDA approved Merck's monoclonal antibody, Enflonsia (clesrovimab), for prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV) in infants under 12 months....

SpliceBio has secured $135 million in a Series B funding round co-led by EQT Life Sciences and Sanofi Ventures, with participation from Roche Ventures and existing investors. The capital will...

FDA halted multiple Gilead phase 1 and phase 2/3 trials for investigational HIV combo drugs following safety signals of immune cell count reductions, delaying critical research and raising...

Argenx announced promising data for its autoimmune drug Vyvgart in two new indications, expanding its therapeutic potential beyond current approvals. The positive results bolster Argenx's pipeline...